Accipio Ix (discontinued)

MaxQ AI, Ltd.

**In January 2022 MaxQ announced the discontinuation of their imaging AI product portfolio.**
AccipioIx is a software workflow tool designed to aid in prioritizing the clinical assessment of adult non-contrast head CT cases with features suggestive of acute intracranial hemorrhage in the acute care environment. AccipioIx analyzes cases using an artificial intelligence algorithm to identify suspected findings. It makes case-level output available to a PACS/workstation for worklist prioritization or triage.

Product specifications

Information source: Vendor
Last updated: Jan. 21, 2022

General
Product name	Accipio Ix (discontinued)
Company	MaxQ AI, Ltd.
Subspeciality	Neuro
Modality	CT
Disease targeted	Intracranial hemorrhage
Key-features	Per-case detection of ICH
Suggested use	Before: adapting worklist order
Data characteristics
Population	Stroke and head trauma patients suspicion of intracranial hemorrhage
Input	Adult non-contrast head CT
Input format	DICOM
Output	Triage with notification
Output format	DICOM Secondary Capture
Technology
Integration	Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration CIS (Clinical Information System), Integration via AI marketplace or distribution platform
Deployment	Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution
Trigger for analysis	Automatically, right after the image acquisition
Processing time
Certification
CE	Certified, Class IIb , MDD
FDA	510(k) cleared, Class II
Market presence
On market since	05-2018
Distribution channels	GE, Philips, FujiFilm, IBM, Nuance, Blackford
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model	Pay-per-use, Subscription
Based on	Number of installations, Number of analyses
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers